Policlinico Umberto I

Running trials

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  REal-life ON PARKinson's - ITaly (REONPARK-IT)

  NCT07403799· Bial - Portela C S.A.· Source

• Recruiting

  Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

  NCT06994377· European Institute of Oncology· Source

• Active, not recruiting

  Racial Disparities in Acute Stroke

  NCT06955442· Fondazione Policlinico Universitario Agostino Gemelli IRCCS· Source

• Recruiting

  Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

  NCT06869473· Phase 2· Gruppo Oncologico del Nord-Ovest· Source

• Active, not recruiting

  A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT06686615· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

  NCT06832371· Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)· Source

• Active, not recruiting

  Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

  NCT06531109· Pfizer· Source

• Recruiting

  Master Framework For Relapse or Refractory Acute Myeloid Leukemia

  NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source

• Recruiting

  Differentiating Heart Disease Between Adult-onset Autoimmune and Type 2 Diabetes

  NCT07911007· University of Roma La Sapienza· Source

• Recruiting

  Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases

  NCT05545007· Istituto Clinico Humanitas· Source

• Recruiting

  Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  NCT05640999· Phase 2· Canadian Cancer Trials Group· Source

• Recruiting

  Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

  NCT05924100· Phase 2· Associazione Qol-one· Source

• Recruiting

  Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

  NCT05601700· Phase 3· Ente Ospedaliero Ospedali Galliera· Source

• Active, not recruiting

  Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

  NCT05382156· RECORDATI GROUP· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Protocol ITANET - Registry

  NCT04282083· Italian Association Neuroendocrine Tumors· Source

• Recruiting

  Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

  NCT03695978· Octapharma· Source

• Recruiting

  Liver Damage and Cardiometabolic Disorders in NAFLD

  NCT04036357· University of Roma La Sapienza· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Amyloidosis1 recruiting
• Childhood cancers1 recruiting
• Endometrial cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Haemophilia1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Metastatic breast cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroendocrine tumours1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  VYxeoS Liposomal Italian Observational Study iN the Real Practice

  NCT06143839· Jazz Pharmaceuticals· Source

• Completed

  The Effect of a Personalized Protein- and Energy-optimized Diet on Muscle Strength in Adult Patients With Chronic Liver Disease

  NCT07625085· University of Roma La Sapienza· Source

• Completed

  Cenobamate in Adults With Focal-Onset Seizures

  NCT05859854· Aziende Chimiche Riunite Angelini Francesco S.p.A· Source

• Completed

  Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

  NCT05323734· Phase 3· Marinus Pharmaceuticals· Source

• Withdrawn

  A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

  NCT04264806· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

  NCT04471428· Phase 3· Hoffmann-La Roche· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· Phase 3· Actelion· Source

• Terminated

  Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease

  NCT02579889· Biotronik SE & Co. KG· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Bladder cancer46 works · 0 trials
• Myeloproliferative neoplasms16 works · 0 trials
• Chronic myeloid leukaemia14 works · 1 trial
• Eosinophilic oesophagitis8 works · 0 trials
• Haemophilia7 works · 1 trial
• Fibromyalgia6 works · 0 trials
• Cushing's syndrome4 works · 1 trial